HCPCS Level II J1744: Injection, icatibant 1 mg
HCPCS Level II code J1744 describes a billed unit for injection of icatibant, 1 mg, used for subcutaneous administration of the bradykinin B2 receptor antagonist; service type: medication administration (injectable therapeutic agent); typical site of service: outpatient clinic, emergency department, or other facility settings where parenteral medications are administered.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J1744 policy alerts
Get alerted when payer policies referencing J1744 are released or updated.
Monitor payer policy activity